1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Butorphanol Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-12L8315
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Butorphanol Market Insights Forecast to 2028
BUY CHAPTERS

Global Butorphanol Market Research Report 2025

Code: QYRE-Auto-12L8315
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Butorphanol Market Size

The global market for Butorphanol was valued at US$ 1889 million in the year 2024 and is projected to reach a revised size of US$ 2715 million by 2031, growing at a CAGR of 5.4% during the forecast period.

Butorphanol Market

Butorphanol Market

Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Butorphanol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Butorphanol.
The Butorphanol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Butorphanol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Butorphanol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Butorphanol Market Report

Report Metric Details
Report Name Butorphanol Market
Accounted market size in year US$ 1889 million
Forecasted market size in 2031 US$ 2715 million
CAGR 5.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Spray
  • Injection
  • Tablet
Segment by Application
  • Human
  • Veterinary
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Santé Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Butorphanol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Butorphanol Market growing?

Ans: The Butorphanol Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the Butorphanol Market size in 2031?

Ans: The Butorphanol Market size in 2031 will be US$ 2715 million.

Who are the main players in the Butorphanol Market report?

Ans: The main players in the Butorphanol Market are Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Santé Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA

What are the Application segmentation covered in the Butorphanol Market report?

Ans: The Applications covered in the Butorphanol Market report are Human, Veterinary

What are the Type segmentation covered in the Butorphanol Market report?

Ans: The Types covered in the Butorphanol Market report are Spray, Injection, Tablet

Recommended Reports

API Drugs

Pain Management

Therapeutic Drug Markets

1 Butorphanol Market Overview
1.1 Product Definition
1.2 Butorphanol by Type
1.2.1 Global Butorphanol Market Value Comparison by Type (2024 VS 2031)
1.2.2 Spray
1.2.3 Injection
1.2.4 Tablet
1.3 Butorphanol by Application
1.3.1 Global Butorphanol Market Value by Application (2024 VS 2031)
1.3.2 Human
1.3.3 Veterinary
1.4 Global Butorphanol Market Size Estimates and Forecasts
1.4.1 Global Butorphanol Revenue 2020-2031
1.4.2 Global Butorphanol Sales 2020-2031
1.4.3 Global Butorphanol Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Butorphanol Market Competition by Manufacturers
2.1 Global Butorphanol Sales Market Share by Manufacturers (2020-2025)
2.2 Global Butorphanol Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Butorphanol Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Butorphanol, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Butorphanol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Butorphanol, Product Type & Application
2.7 Global Key Manufacturers of Butorphanol, Date of Enter into This Industry
2.8 Global Butorphanol Market Competitive Situation and Trends
2.8.1 Global Butorphanol Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Butorphanol Players Market Share by Revenue
2.8.3 Global Butorphanol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Butorphanol Market Scenario by Region
3.1 Global Butorphanol Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Butorphanol Sales by Region: 2020-2031
3.2.1 Global Butorphanol Sales by Region: 2020-2025
3.2.2 Global Butorphanol Sales by Region: 2026-2031
3.3 Global Butorphanol Revenue by Region: 2020-2031
3.3.1 Global Butorphanol Revenue by Region: 2020-2025
3.3.2 Global Butorphanol Revenue by Region: 2026-2031
3.4 North America Butorphanol Market Facts & Figures by Country
3.4.1 North America Butorphanol Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Butorphanol Sales by Country (2020-2031)
3.4.3 North America Butorphanol Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Butorphanol Market Facts & Figures by Country
3.5.1 Europe Butorphanol Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Butorphanol Sales by Country (2020-2031)
3.5.3 Europe Butorphanol Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Butorphanol Market Facts & Figures by Region
3.6.1 Asia Pacific Butorphanol Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Butorphanol Sales by Region (2020-2031)
3.6.3 Asia Pacific Butorphanol Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Butorphanol Market Facts & Figures by Country
3.7.1 Latin America Butorphanol Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Butorphanol Sales by Country (2020-2031)
3.7.3 Latin America Butorphanol Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Butorphanol Market Facts & Figures by Country
3.8.1 Middle East and Africa Butorphanol Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Butorphanol Sales by Country (2020-2031)
3.8.3 Middle East and Africa Butorphanol Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Butorphanol Sales by Type (2020-2031)
4.1.1 Global Butorphanol Sales by Type (2020-2025)
4.1.2 Global Butorphanol Sales by Type (2026-2031)
4.1.3 Global Butorphanol Sales Market Share by Type (2020-2031)
4.2 Global Butorphanol Revenue by Type (2020-2031)
4.2.1 Global Butorphanol Revenue by Type (2020-2025)
4.2.2 Global Butorphanol Revenue by Type (2026-2031)
4.2.3 Global Butorphanol Revenue Market Share by Type (2020-2031)
4.3 Global Butorphanol Price by Type (2020-2031)
5 Segment by Application
5.1 Global Butorphanol Sales by Application (2020-2031)
5.1.1 Global Butorphanol Sales by Application (2020-2025)
5.1.2 Global Butorphanol Sales by Application (2026-2031)
5.1.3 Global Butorphanol Sales Market Share by Application (2020-2031)
5.2 Global Butorphanol Revenue by Application (2020-2031)
5.2.1 Global Butorphanol Revenue by Application (2020-2025)
5.2.2 Global Butorphanol Revenue by Application (2026-2031)
5.2.3 Global Butorphanol Revenue Market Share by Application (2020-2031)
5.3 Global Butorphanol Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hikma Pharmaceuticals
6.1.1 Hikma Pharmaceuticals Company Information
6.1.2 Hikma Pharmaceuticals Description and Business Overview
6.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
6.1.5 Hikma Pharmaceuticals Recent Developments/Updates
6.2 Athanas Enterprise Private Limited
6.2.1 Athanas Enterprise Private Limited Company Information
6.2.2 Athanas Enterprise Private Limited Description and Business Overview
6.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
6.2.5 Athanas Enterprise Private Limited Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Butorphanol Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Apothecon Pharmaceuticals
6.4.1 Apothecon Pharmaceuticals Company Information
6.4.2 Apothecon Pharmaceuticals Description and Business Overview
6.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
6.4.5 Apothecon Pharmaceuticals Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mylan Butorphanol Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Novex Pharma
6.6.1 Novex Pharma Company Information
6.6.2 Novex Pharma Description and Business Overview
6.6.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novex Pharma Butorphanol Product Portfolio
6.6.5 Novex Pharma Recent Developments/Updates
6.7 Bristol Myers Squibb
6.7.1 Bristol Myers Squibb Company Information
6.7.2 Bristol Myers Squibb Description and Business Overview
6.7.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol Myers Squibb Butorphanol Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Sanochemia Pharmazeutika
6.8.1 Sanochemia Pharmazeutika Company Information
6.8.2 Sanochemia Pharmazeutika Description and Business Overview
6.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
6.8.5 Sanochemia Pharmazeutika Recent Developments/Updates
6.9 Selectavet
6.9.1 Selectavet Company Information
6.9.2 Selectavet Description and Business Overview
6.9.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Selectavet Butorphanol Product Portfolio
6.9.5 Selectavet Recent Developments/Updates
6.10 Richter Pharma Ag
6.10.1 Richter Pharma Ag Company Information
6.10.2 Richter Pharma Ag Description and Business Overview
6.10.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Richter Pharma Ag Butorphanol Product Portfolio
6.10.5 Richter Pharma Ag Recent Developments/Updates
6.11 Troy Laboratories Nz
6.11.1 Troy Laboratories Nz Company Information
6.11.2 Troy Laboratories Nz Description and Business Overview
6.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Troy Laboratories Nz Butorphanol Product Portfolio
6.11.5 Troy Laboratories Nz Recent Developments/Updates
6.12 Animedica
6.12.1 Animedica Company Information
6.12.2 Animedica Description and Business Overview
6.12.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Animedica Butorphanol Product Portfolio
6.12.5 Animedica Recent Developments/Updates
6.13 Boehringer Ingelheim Santé Animale
6.13.1 Boehringer Ingelheim Santé Animale Company Information
6.13.2 Boehringer Ingelheim Santé Animale Description and Business Overview
6.13.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
6.13.5 Boehringer Ingelheim Santé Animale Recent Developments/Updates
6.14 Ausrichter
6.14.1 Ausrichter Company Information
6.14.2 Ausrichter Description and Business Overview
6.14.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ausrichter Butorphanol Product Portfolio
6.14.5 Ausrichter Recent Developments/Updates
6.15 Zoetis
6.15.1 Zoetis Company Information
6.15.2 Zoetis Description and Business Overview
6.15.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Zoetis Butorphanol Product Portfolio
6.15.5 Zoetis Recent Developments/Updates
6.16 Dechra Pharmaceuticals
6.16.1 Dechra Pharmaceuticals Company Information
6.16.2 Dechra Pharmaceuticals Description and Business Overview
6.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
6.16.5 Dechra Pharmaceuticals Recent Developments/Updates
6.17 Faunapharma
6.17.1 Faunapharma Company Information
6.17.2 Faunapharma Description and Business Overview
6.17.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Faunapharma Butorphanol Product Portfolio
6.17.5 Faunapharma Recent Developments/Updates
6.18 Merck KGaA
6.18.1 Merck KGaA Company Information
6.18.2 Merck KGaA Description and Business Overview
6.18.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Merck KGaA Butorphanol Product Portfolio
6.18.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Butorphanol Industry Chain Analysis
7.2 Butorphanol Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Butorphanol Production Mode & Process Analysis
7.4 Butorphanol Sales and Marketing
7.4.1 Butorphanol Sales Channels
7.4.2 Butorphanol Distributors
7.5 Butorphanol Customer Analysis
8 Butorphanol Market Dynamics
8.1 Butorphanol Industry Trends
8.2 Butorphanol Market Drivers
8.3 Butorphanol Market Challenges
8.4 Butorphanol Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Butorphanol Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Butorphanol Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Butorphanol Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Butorphanol Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Butorphanol Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Butorphanol Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Butorphanol Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Butorphanol Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Butorphanol, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Butorphanol, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Butorphanol, Product Type & Application
 Table 12. Global Key Manufacturers of Butorphanol, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Butorphanol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butorphanol as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Butorphanol Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Butorphanol Sales by Region (2020-2025) & (K Units)
 Table 18. Global Butorphanol Sales Market Share by Region (2020-2025)
 Table 19. Global Butorphanol Sales by Region (2026-2031) & (K Units)
 Table 20. Global Butorphanol Sales Market Share by Region (2026-2031)
 Table 21. Global Butorphanol Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Butorphanol Revenue Market Share by Region (2020-2025)
 Table 23. Global Butorphanol Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Butorphanol Revenue Market Share by Region (2026-2031)
 Table 25. North America Butorphanol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Butorphanol Sales by Country (2020-2025) & (K Units)
 Table 27. North America Butorphanol Sales by Country (2026-2031) & (K Units)
 Table 28. North America Butorphanol Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Butorphanol Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Butorphanol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Butorphanol Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Butorphanol Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Butorphanol Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Butorphanol Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Butorphanol Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Butorphanol Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Butorphanol Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Butorphanol Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Butorphanol Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Butorphanol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Butorphanol Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Butorphanol Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Butorphanol Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Butorphanol Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Butorphanol Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Butorphanol Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Butorphanol Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Butorphanol Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Butorphanol Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Butorphanol Sales (K Units) by Type (2020-2025)
 Table 51. Global Butorphanol Sales (K Units) by Type (2026-2031)
 Table 52. Global Butorphanol Sales Market Share by Type (2020-2025)
 Table 53. Global Butorphanol Sales Market Share by Type (2026-2031)
 Table 54. Global Butorphanol Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Butorphanol Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Butorphanol Revenue Market Share by Type (2020-2025)
 Table 57. Global Butorphanol Revenue Market Share by Type (2026-2031)
 Table 58. Global Butorphanol Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Butorphanol Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Butorphanol Sales (K Units) by Application (2020-2025)
 Table 61. Global Butorphanol Sales (K Units) by Application (2026-2031)
 Table 62. Global Butorphanol Sales Market Share by Application (2020-2025)
 Table 63. Global Butorphanol Sales Market Share by Application (2026-2031)
 Table 64. Global Butorphanol Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Butorphanol Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Butorphanol Revenue Market Share by Application (2020-2025)
 Table 67. Global Butorphanol Revenue Market Share by Application (2026-2031)
 Table 68. Global Butorphanol Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Butorphanol Price (US$/Unit) by Application (2026-2031)
 Table 70. Hikma Pharmaceuticals Company Information
 Table 71. Hikma Pharmaceuticals Description and Business Overview
 Table 72. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Hikma Pharmaceuticals Butorphanol Product
 Table 74. Hikma Pharmaceuticals Recent Developments/Updates
 Table 75. Athanas Enterprise Private Limited Company Information
 Table 76. Athanas Enterprise Private Limited Description and Business Overview
 Table 77. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Athanas Enterprise Private Limited Butorphanol Product
 Table 79. Athanas Enterprise Private Limited Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Butorphanol Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Apothecon Pharmaceuticals Company Information
 Table 86. Apothecon Pharmaceuticals Description and Business Overview
 Table 87. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Apothecon Pharmaceuticals Butorphanol Product
 Table 89. Apothecon Pharmaceuticals Recent Developments/Updates
 Table 90. Mylan Company Information
 Table 91. Mylan Description and Business Overview
 Table 92. Mylan Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mylan Butorphanol Product
 Table 94. Mylan Recent Developments/Updates
 Table 95. Novex Pharma Company Information
 Table 96. Novex Pharma Description and Business Overview
 Table 97. Novex Pharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Novex Pharma Butorphanol Product
 Table 99. Novex Pharma Recent Developments/Updates
 Table 100. Bristol Myers Squibb Company Information
 Table 101. Bristol Myers Squibb Description and Business Overview
 Table 102. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol Myers Squibb Butorphanol Product
 Table 104. Bristol Myers Squibb Recent Developments/Updates
 Table 105. Sanochemia Pharmazeutika Company Information
 Table 106. Sanochemia Pharmazeutika Description and Business Overview
 Table 107. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sanochemia Pharmazeutika Butorphanol Product
 Table 109. Sanochemia Pharmazeutika Recent Developments/Updates
 Table 110. Selectavet Company Information
 Table 111. Selectavet Description and Business Overview
 Table 112. Selectavet Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Selectavet Butorphanol Product
 Table 114. Selectavet Recent Developments/Updates
 Table 115. Richter Pharma Ag Company Information
 Table 116. Richter Pharma Ag Description and Business Overview
 Table 117. Richter Pharma Ag Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Richter Pharma Ag Butorphanol Product
 Table 119. Richter Pharma Ag Recent Developments/Updates
 Table 120. Troy Laboratories Nz Company Information
 Table 121. Troy Laboratories Nz Description and Business Overview
 Table 122. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Troy Laboratories Nz Butorphanol Product
 Table 124. Troy Laboratories Nz Recent Developments/Updates
 Table 125. Animedica Company Information
 Table 126. Animedica Description and Business Overview
 Table 127. Animedica Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Animedica Butorphanol Product
 Table 129. Animedica Recent Developments/Updates
 Table 130. Boehringer Ingelheim Santé Animale Company Information
 Table 131. Boehringer Ingelheim Santé Animale Description and Business Overview
 Table 132. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Boehringer Ingelheim Santé Animale Butorphanol Product
 Table 134. Boehringer Ingelheim Santé Animale Recent Developments/Updates
 Table 135. Ausrichter Company Information
 Table 136. Ausrichter Description and Business Overview
 Table 137. Ausrichter Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Ausrichter Butorphanol Product
 Table 139. Ausrichter Recent Developments/Updates
 Table 140. Zoetis Company Information
 Table 141. Zoetis Description and Business Overview
 Table 142. Zoetis Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Zoetis Butorphanol Product
 Table 144. Zoetis Recent Developments/Updates
 Table 145. Dechra Pharmaceuticals Company Information
 Table 146. Dechra Pharmaceuticals Description and Business Overview
 Table 147. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Dechra Pharmaceuticals Butorphanol Product
 Table 149. Dechra Pharmaceuticals Recent Developments/Updates
 Table 150. Faunapharma Company Information
 Table 151. Faunapharma Description and Business Overview
 Table 152. Faunapharma Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Faunapharma Butorphanol Product
 Table 154. Faunapharma Recent Developments/Updates
 Table 155. Merck KGaA Company Information
 Table 156. Merck KGaA Description and Business Overview
 Table 157. Merck KGaA Butorphanol Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Merck KGaA Butorphanol Product
 Table 159. Merck KGaA Recent Developments/Updates
 Table 160. Key Raw Materials Lists
 Table 161. Raw Materials Key Suppliers Lists
 Table 162. Butorphanol Distributors List
 Table 163. Butorphanol Customers List
 Table 164. Butorphanol Market Trends
 Table 165. Butorphanol Market Drivers
 Table 166. Butorphanol Market Challenges
 Table 167. Butorphanol Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources
 Table 171. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Butorphanol
 Figure 2. Global Butorphanol Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Butorphanol Market Share by Type: 2024 & 2031
 Figure 4. Spray Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Tablet Product Picture
 Figure 7. Global Butorphanol Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Butorphanol Market Share by Application: 2024 & 2031
 Figure 9. Human
 Figure 10. Veterinary
 Figure 11. Global Butorphanol Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Butorphanol Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Butorphanol Sales (2020-2031) & (K Units)
 Figure 14. Global Butorphanol Average Price (US$/Unit) & (2020-2031)
 Figure 15. Butorphanol Report Years Considered
 Figure 16. Butorphanol Sales Share by Manufacturers in 2024
 Figure 17. Global Butorphanol Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Butorphanol Players: Market Share by Revenue in Butorphanol in 2024
 Figure 19. Butorphanol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Butorphanol Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Butorphanol Sales Market Share by Country (2020-2031)
 Figure 22. North America Butorphanol Revenue Market Share by Country (2020-2031)
 Figure 23. United States Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Butorphanol Sales Market Share by Country (2020-2031)
 Figure 26. Europe Butorphanol Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Butorphanol Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Butorphanol Revenue Market Share by Region (2020-2031)
 Figure 34. China Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Butorphanol Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Butorphanol Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Butorphanol Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Butorphanol Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Butorphanol Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Butorphanol by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Butorphanol by Type (2020-2031)
 Figure 55. Global Butorphanol Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Butorphanol by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Butorphanol by Application (2020-2031)
 Figure 58. Global Butorphanol Price (US$/Unit) by Application (2020-2031)
 Figure 59. Butorphanol Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure